Domiciliary treatment of febrile episodes in cancer patients: a prospective randomized trial comparing oral versus parenteral empirical antibiotic treatment

This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. The authors concluded that domiciliary (out-patient) treatment of febrile episodes in low-risk neutropenic and nonneutropenic cancer patients is feasible and effective and that either oral ciprofloxacin or ceftriaxone can be used. However, the authors stated that oral ciprofloxacin was less expensive and thus the more preferable treatment option.